Nucleic Acid-Based Motor End Plate Regulation

ID202606424APending Publication Date: 2026-08-06PRECLINICS DISCOVERY GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
ID · ID
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-02-20
Publication Date
2026-08-06
Patent Text Reader

Abstract

The present invention relates to a nucleic acid molecule for modulating neuromuscular transmission, said nucleic acid molecule comprising a sequence encoding one or more motor endplate receptors or fragments thereof. The present invention further relates to a fusion protein, preferably comprising one or more features of one or more of the foregoing Claims, said fusion protein comprising a motor endplate receptor and / or fragments thereof, wherein said motor endplate receptor is an acetylcholine receptor (AChR), a muscle-specific tyrosine kinase (MuSK) receptor, and / or a glutamate receptor, and / or fragments thereof, and / or a neurotoxin, wherein said neurotoxin is botulinum toxin (BoNT) and / or tetanus toxin.
Need to check novelty before this filing date? Find Prior Art